NCT04131764

Brief Summary

This is both a prospective and retrospective study of patients with a known diagnosis of optic neuritis (ON) only, multiple sclerosis (MS) with ON, or neuromyelitis spectrum disorder (NMOSD) with ON. There will be no requirement for blinding (patient or assessor) and data collected with the Reflex app will be compared against other data that track optic nerve functional status, such as optical coherence tomography (OCT), visual fields (VF), low-contrast sensitivity, MRI orbits/brain and visual evoked potentials (VEP). Patients who have any diagnosis of ON, with or without a diagnosis of MS or NMOSD and who have had testing using other modalities such as VEPs, VF, low-contrast sensitivity studies, OCT, and MRI of brain or orbits will be included as retrospective subjects in the study. In this cohort, RAPD assessments will be completed and compared to against the data that has accrued as noted.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
112

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 4, 2019

Completed
13 days until next milestone

First Submitted

Initial submission to the registry

October 17, 2019

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 18, 2019

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 6, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 6, 2022

Completed
Last Updated

November 14, 2022

Status Verified

November 1, 2022

Enrollment Period

2.9 years

First QC Date

October 17, 2019

Last Update Submit

November 9, 2022

Conditions

Keywords

multiple sclerosisMSNeuromyelitis optica spectrum disorderNMOSDoptic neuritispupillary responseRAPDrapid afferent pupillary defect

Outcome Measures

Primary Outcomes (2)

  • Feasibility of device for diagnosis of ON

    Feasibility of using quantified pupillary responses as a surrogate marker for assessment of optic nerve dysfunction in ON, MS, and NMOSD.

    10 seconds

  • Comparative data assessment

    Comparing Reflex with other routine clinical methods of evaluating optic nerve dysfunction

    Time of app scan (10s) plus time to compare data (1-2 hours)

Study Arms (3)

Optic neuritis diagnosis only

Patients who have a diagnosis of optic neuritis, without a diagnosis of MS or NMOSD.

Diagnostic Test: Reflex (Brightlamp Inc., Purdue University)

ON and multiple sclerosis

Patients who have a diagnosis of optic neuritis AND multiple sclerosis.

Diagnostic Test: Reflex (Brightlamp Inc., Purdue University)

ON and NMOSD

Patients who have a diagnosis of optic neuritis and neuromyelitis optica spectrum disorder.

Diagnostic Test: Reflex (Brightlamp Inc., Purdue University)

Interventions

The Reflex pupillometer is a mobile based application that provides a quantitative way to monitor pupillary activity and responsiveness. It uses the mobile phone as a source of light and records pupillary response, as well as analyzes and compiles the data. It produces quantitative measures such as latency, minimum and maximum pupil diameter, maximum and average constriction velocity, dilation velocity, and 75% recovery time.

ON and NMOSDON and multiple sclerosisOptic neuritis diagnosis only

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Eligible patients include those seen at the University of Kentucky during routine clinical neurology visits between the ages of 18 and 90 years who have been diagnosed with optic neuritis, optic neuritis and multiple sclerosis, or optic neuritis and neuromyelitis optica spectrum disorder and have had at least one previous test that tracks optic nerve function.

You may qualify if:

  • Male or female patients ages 18-90 years
  • Signed informed consent
  • Have been diagnosed with optic neuritis (ON) only, MS and ON, or NMOSD and ON
  • Have had at least one previous test to track optical nerve function

You may not qualify if:

  • Are pregnant or nursing
  • Are children (age \<18 years)
  • Do not have a diagnosis of optic neuritis (ON)
  • Have a diagnosis of MS or NMOSD without a diagnosis of ON as well

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kentucky

Lexington, Kentucky, 40536, United States

Location

Related Links

MeSH Terms

Conditions

Multiple SclerosisOptic NeuritisNeuromyelitis Optica

Interventions

Reflex

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesOptic Nerve DiseasesCranial Nerve DiseasesEye DiseasesMyelitis, Transverse

Intervention Hierarchy (Ancestors)

Neurologic ExaminationDiagnostic Techniques, NeurologicalDiagnostic Techniques and ProceduresDiagnosisPhysical ExaminationNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Jagannadha Avasarala, MD PhD

    University of Kentucky

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Professor of Neurology

Study Record Dates

First Submitted

October 17, 2019

First Posted

October 18, 2019

Study Start

October 4, 2019

Primary Completion

September 6, 2022

Study Completion

September 6, 2022

Last Updated

November 14, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations